Skip to content

Establishment of a Tissue Registry for Hepatocellular Carcinoma Specimens

Establishment of a Tissue Registry for Hepatocellular Carcinoma Specimens for Genetic and Histologic Research

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05935189
Acronym
TIR-HCC
Enrollment
500
Registered
2023-07-07
Start date
2023-07-01
Completion date
2028-07-01
Last updated
2023-07-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatocellular Carcinoma

Brief summary

The goal of the study is to establish a cancer registry to facilitate research and assist in the identification of additional risk factors for hepatocellular carcinoma. The main objectives are: 1. provide a mechanism to store the information about subjects with hepatocellular carcinoma 2. use of tissue samples for translational/further research purposes

Detailed description

The Establishment of a Tissue Registry for Hepatocellular Carcinoma biopsy specimens for genetic and histologic research (TIR-HCC) is a project aimed at addressing the high incidence rates of primary liver cancer in Armenia. This initiative seeks to establish a cancer registry to support research efforts and identify additional risk factors associated with hepatocellular carcinoma (HCC). The study will involve patients of Armenian descent who exhibit clinical, biochemical, and imaging evidence of hepatocellular carcinoma. Data collection will include tissue and blood samples, which will undergo histologic and genetic analyses. Additionally, relevant clinical history, laboratory results, imaging findings, and gut microbiota profiles will be collected. To ensure a comprehensive dataset, samples will be collected from eight institutions in Armenia. The project aims to accumulate data from a total of 500 patients, providing a substantial pool for research and analysis. By establishing the TIR-HCC registry, researchers hope to contribute to the understanding of hepatocellular carcinoma and potentially identify new risk factors associated with the disease. The collected data will aid in advancing knowledge of HCC and guide future strategies for prevention, early detection, and treatment.

Interventions

None listed

Sponsors

Nikomed Medical Center
Lead SponsorNETWORK

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Patients with biopsy-confirmed diagnosis of HCC * Armenian descent * Having given their signed Informed consent

Exclusion criteria

* Failure to obtain informed consent

Design outcomes

Primary

MeasureTime frameDescription
Creation of a registry5 yearThe primary outcome of this study is to provide a mechanism to store the information about subjects with hepatocellular carcinoma. The outcome will be measured by the number of patients involved in the registry, measured by absolute numbers. The target number is 500 patients.

Countries

Armenia

Contacts

Primary ContactTigran Aghabekyan
tigran1999@yahoo.com99750721
Backup ContactHasmik Ghazinian, MD
ghazinian@gmail.com91423802

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026